Larvol Delta - Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Vepdegestrant-in-Patients-with-Advanced-Breast-Cancer

samuraciclib (CT7001) - Carrick Therap

vepdegestrant (ARV-471) - Arvinas, Pfizer

https://www.globenewswire.com/news-release/2024/02/14/2829038/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Vepdegestrant-in-Patients-with-Advanced-Breast-Cancer.html

Feb 14, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next